Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings
Financial Results

The Joint Corp Reports $13.55M Revenue in Q3 2026 Amid Strategic Refranchising Shift

The Joint Corp reported a slight revenue increase to $13.55 million in Q3 2026, though net income swung to a loss of $0.12 million. The results highlight a significant structural transition as the company refranchises company-owned clinics, leading to a substantial reduction in total assets.

Wheelchair, disability, injured, disabled. Stock photo illustrating The Joint's financial results story.
JOINT Corp · Photo: stevepb / Pixabay
Results at a glance · $ Million
Metric Q3-26Q3-25
Revenue 13.5513.38
Pretax Income 1.470.30
Net Income -0.120.86
Diluted EPS -0.010.06
Net Income YoY
-113.7%

Key highlights

  • Revenue reached $13.55 million, up from $13.38 million in the prior year's third quarter
  • Net income decreased 113.7% year-over-year to a loss of $0.12 million
  • Pretax income improved significantly to $1.47 million from $0.30 million in Q3 2025
  • Total assets declined to $40.7 million from $61.0 million at year-end 2025
  • Full-year 2026 system-wide sales guidance updated to between $508 million and $512 million

How the Period Went

The Joint Corp’s top-line performance remained steady during the third quarter of 2026, with revenue reaching $13.55 million, a slight increase from $13.38 million in the same period last year. However, the bottom line experienced pressure as net income dropped by 113.7% to a loss of $0.12 million. This contrasted with the $0.86 million profit recorded in Q3 2025. Diluted earnings per share shifted from $0.06 to -$0.01. Despite the net loss, the company saw a rise in pretax income, which climbed to $1.47 million from $0.30 million, suggesting that the primary earnings drag originated from discontinued operations or non-operating adjustments.

Margins and Profitability

Profitability in the quarter was largely influenced by the company's transition away from corporate-owned clinic management. While pretax income saw a five-fold increase to $1.47 million, the net loss reflects the costs associated with the ongoing refranchising strategy. A major driver of balance sheet contraction was the reduction in assets related to discontinued operations, which fell from $61.0 million at the end of 2025 to $40.7 million as of September 30, 2026. This shift aims to optimize the capital structure by moving toward a higher-margin franchise-fee model, even if it creates short-term volatility in reported net earnings.

Business Overview

The Joint Corp operates as a leading franchisor and operator of chiropractic clinics across the United States. Its business model centers on providing accessible, no-appointment-needed chiropractic care through a private-pay system, bypassing traditional insurance complexities. The company earns revenue through royalty fees from franchisees, marketing fund contributions, and the operation of a diminishing pool of company-owned clinics. By focusing on the domestic chiropractic market, The Joint serves a broad consumer base seeking routine wellness and pain management in a retail-like environment. The company currently manages a $0 backlog, consistent with its walk-in clinic business model.

Financial Context

The Joint Corp’s current valuation reflects its transitional phase, with a P/E ratio of 52.6x and a market capitalization of approximately $100.9 million. The stock has faced some recent headwinds, evidenced by a -10.99% decline over the last quarter, though it has stabilized recently with an RSI of 49.9. While quarterly revenue has fluctuated—peaking at $15.2 million in Q2 2026 before settling at $13.55 million this quarter—the company maintains a strong market position within the medical care facilities industry. Management has reaffirmed its full-year Adjusted EBITDA guidance of $12.5 million to $13.5 million, according to reports from GuruFocus.

JOINT Corp share price · last month
Line chart of JOINT Corp's share price over the last month, from $7.27 on 19 Oct → $6.66 on 16 Nov; our story on 6 Nov at $7.37.

Down 9.6% since our story on 6 Nov: $7.37 when we broke it → $6.66 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$7.27
20 Oct$7.19
21 Oct$7.17
22 Oct$7.37
23 Oct$7.21
26 Oct$7.28
27 Oct$7.21
28 Oct$7.26
29 Oct$7.36
30 Oct$7.03
2 Nov$7.32
3 Nov$7.20
4 Nov$7.51
5 Nov$7.37
6 Nov$6.85
9 Nov$6.65
10 Nov$6.83
11 Nov$6.80
12 Nov$6.69
13 Nov$6.94
16 Nov$6.66

Industry Landscape

The chiropractic sector continues to benefit from an aging population and a growing preference for non-opioid pain management solutions. However, the industry faces persistent macroeconomic volatility and rising labor costs for skilled healthcare professionals. Peers in the specialized wellness and outpatient facility space have also encountered fluctuating demand as consumer discretionary spending remains under pressure. The Joint’s move to refranchise aligns with broader industry trends where healthcare operators seek to offload the capital intensity of physical locations to third-party owners, focusing instead on high-margin brand management and system-wide technology integration.

Recent quarters and guidance
DateAnnouncementAmount
05 Nov 2026Q3 2026 financial resultsSource: globenewswire.com$13.6 Million
06 Aug 2026Q2 2026 financial resultsSource: ir.thejoint.com$15.2 Million
07 May 2026Q1 2026 financial resultsSource: ir.thejoint.com$14.8 Million
12 Mar 2026Q4 2025 financial resultsSource: ir.thejoint.com$15.2 Million
06 Nov 2025Q3 2025 financial resultsSource: ir.thejoint.com$13.4 Million
07 Aug 2025Q2 2025 financial resultsSource: ir.thejoint.com$13.3 Million
JOINT Corp · financial snapshot
Share price$7.37
Market cap$101M
Revenue (annual)$55M
P/E (TTM)52.6×
1-month price change+3.66%
SectorHealthcareMedical Care Facilities

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.

Source verified

SEC filing by The Joint Corp. announcing its financial results for the quarter ended September 30, 2026.

Read the filing ↗

Track JOINT Corp live

Get the next JOINT Corp SEC filing seconds after it lands.

More in Results & Earnings

All →

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.